Anacor Pharmaceuticals Reports Second Quarter 2011 financial Results MarketWatch (press release) We are enrolling patients in our two state of matter 3 trials of AN2690 for onychomycosis, we realized our final Phase 2b trial of AN2728 for psoriasis and are preparing for our End of Phase 2 meeting with the FDA, and we announced that our married person GSK ... and more » Link To Article
No comments:
Post a Comment